133 related articles for article (PubMed ID: 17222909)
1. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit.
Nishiyama Y; Karle S; Planque S; Taguchi H; Paul S
Mol Immunol; 2007 Apr; 44(10):2707-18. PubMed ID: 17222909
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
[TBL] [Abstract][Full Text] [Related]
3. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
4. Mapping the Ig superantigen-binding site of HIV-1 gp120.
Goodglick L; Zevit N; Neshat MS; Braun J
J Immunol; 1995 Dec; 155(11):5151-9. PubMed ID: 7594524
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic activity of an antibody light chain.
Sun M; Gao QS; Li L; Paul S
J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
[TBL] [Abstract][Full Text] [Related]
6. [Cloning of human monoclonal Fab fragments against HIV-1 gp120 peptide binding chemokine receptor from phage Fab antibody library].
Shen H; Mao P; Hong S; Hou J; Yang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):357-60. PubMed ID: 12665905
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine.
Planque SA; Mitsuda Y; Nishiyama Y; Karle S; Boivin S; Salas M; Morris MK; Hara M; Liao G; Massey RJ; Hanson CV; Paul S
J Immunol; 2012 Dec; 189(11):5367-81. PubMed ID: 23089396
[TBL] [Abstract][Full Text] [Related]
8. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.
de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T
J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421
[TBL] [Abstract][Full Text] [Related]
9. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
[TBL] [Abstract][Full Text] [Related]
10. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
[TBL] [Abstract][Full Text] [Related]
11. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity.
Suzuki K; Akahori Y; Asano Y; Kurosawa Y; Shiraki K
J Med Virol; 2007 Jun; 79(6):852-62. PubMed ID: 17457901
[TBL] [Abstract][Full Text] [Related]
12. Evidence for distinct contributions of heavy and light chains to restriction of antibody recognition of the HIV-1 principal neutralization determinant.
Watkins BA; Davis AE; Fiorentini S; di Marzo Veronese F; Reitz MS
J Immunol; 1996 Feb; 156(4):1676-83. PubMed ID: 8568275
[TBL] [Abstract][Full Text] [Related]
13. A phage-displayed single chain variable fragment that interacts with hepatitis B core antigen: library construction, selection and diagnosis.
Tan GH; Yusoff K; Seow HF; Tan WS
J Clin Virol; 2007 Jan; 38(1):49-56. PubMed ID: 17074533
[TBL] [Abstract][Full Text] [Related]
14. Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides.
Odintsova ES; Baranova SV; Dmitrenok PS; Calmels C; Parissi V; Andreola ML; Buneva VN; Nevinsky GA
J Mol Recognit; 2012 Apr; 25(4):193-207. PubMed ID: 22434709
[TBL] [Abstract][Full Text] [Related]
15. [Construction and screening of type 1 human immunodeficiency virus specific phage antibodies combinatorial library].
He Y; Wang X; Liu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):33-7. PubMed ID: 12515168
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus: molecular cloning and analysis of 22 individual recombinant monoclonal kappa light chains specifically hydrolyzing human myelin basic protein.
Timofeeva AM; Buneva VN; Nevinsky GA
J Mol Recognit; 2015 Oct; 28(10):614-27. PubMed ID: 25867248
[TBL] [Abstract][Full Text] [Related]
17. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.
Planque S; Mitsuda Y; Taguchi H; Salas M; Morris MK; Nishiyama Y; Kyle R; Okhuysen P; Escobar M; Hunter R; Sheppard HW; Hanson C; Paul S
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1541-54. PubMed ID: 18160012
[TBL] [Abstract][Full Text] [Related]
18. [Construction and preliminary panning of Fab phage display antibody library against respiratory syncytial virus].
Wang ZH; Zhang GC; Li AM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):681-5. PubMed ID: 19102829
[TBL] [Abstract][Full Text] [Related]
19. Tracking immunoglobulin variable-gene expression in HIV infection.
Zouali M
Appl Biochem Biotechnol; 2000; 83(1-3):13-28; discussion 28-9, 145-53. PubMed ID: 10826946
[TBL] [Abstract][Full Text] [Related]
20. Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies.
Nishiyama Y; Karle S; Mitsuda Y; Taguchi H; Planque S; Salas M; Hanson C; Paul S
J Mol Recognit; 2006; 19(5):423-31. PubMed ID: 16838382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
